3DM Inc.

Cell-based research, bioproduction, drug discovery

3DM is a privately-held specialty biomaterials and medical device company headquartered in Cambridge, Massachusetts. The patented technology, exclusively licensed from Massachusetts Institute of Technology, was pioneered through the work and expertise of Drs. Alan Grodzinsky, Robert Langer, Alexander Rich, Carlos Semino, and Shuguang Zhang.

Zen Chu, President, Founder
Lisa Spirio, Ph.D., Director of R&D, Co-Founder

Adam Kirsch
John Maki
Shuguang Zhang, Ph.D.
Zen Chu

Shuguang Zhang, Ph.D.
Alan Grodzinsky, Sc.D.
Alexander Rich, M.D.
Carlos Semino, Ph.D.
Robert Langer, Sc.D.,Chair
Mikael Eliasson, M.D., Ph.D.
Shahe Fereshetian, M.D.
Prof. Julie Glowacki, Ph.D.
Tan Ince, M.D., Ph.D.
Jeffrey Popma, M.D.

P.O. Box 425025
Cambridge, MA 02142
USA
Phone:+1-877-430-9595

PuraMatrix (TM) can be used to create synthetic self-assembling peptide nanofibre scaffolds and defined 3-D microenvironments. PuraMatrix can be used in drug discovery assays, bioproduction, tissue engineering, and cell-based assays including cell migration and invasion, angiogenesis, neurite outgrowth, and hepatocyte functionality and toxicity. The matrix won the International Awards For Biomaterial Nanotechnology & Regenerative Medicine in March 2004.